NKTR
Nektar Therapeutics
42.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Nektar Therapeutics (NKTR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42 | -47 | -48 | -38 | -44 | -46 | -49 | -46 | -49 | -65 | -44 | -76 | -234 | |
| 1.7 | 1.7 | 1.6 | 1.5 | 1.0 | 0.3 | 0.4 | -0.7 | 0.2 | -0.4 | 0.2 | 0.2 | 0.1 | |
| 8.1 | 7.3 | 6.0 | 5.4 | 5.4 | 4.8 | 3.9 | 3.5 | 3.1 | 2.2 | 3.4 | 3.4 | 12 | |
| -3.2 | -4.7 | -6.6 | 11 | 1.1 | -12 | -0.1 | -3.6 | -10 | -23 | -0.1 | -47 | -80 | |
| 0.0 | 0.2 | 0.2 | 0.2 | 0.7 | 0.5 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | |
| 56 | 17 | 19 | 17 | 46 | 60 | 44 | 50 | -95 | 0.4 | -351 | -399 | -844 | |
| 0.0 | – | -3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| -65 | 0.0 | 42 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 142 | 39 | 530 | 365 | 1,074 | |
| 14 | -30 | 15 | -21 | 2.1 | 14 | -5.4 | 4.1 | -2.0 | -1.2 | 129 | -110 | 15 | |
| -42 | -47 | -48 | -38 | -45 | -47 | -49 | -46 | -49 | -65 | -44 | -76 | -234 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.